Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
14.58
-0.12 (-0.82%)
Dec 5, 2025, 4:00 PM EST - Market closed
Phathom Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Phathom Pharmaceuticals stock have an average target of 17.6, with a low estimate of 5.00 and a high estimate of 28. The average target predicts an increase of 20.71% from the current stock price of 14.58.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 31, 2025.
Analyst Ratings
The average analyst rating for Phathom Pharmaceuticals stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $26 | Strong Buy | Maintains | $20 → $26 | +78.33% | Oct 31, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $17 | Strong Buy | Maintains | $12 → $17 | +16.60% | Jun 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +37.17% | Jun 9, 2025 |
| Needham | Needham | Strong Buy Maintains $28 | Strong Buy | Maintains | $28 | +92.04% | Jun 6, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $19 → $12 | Strong Buy | Maintains | $19 → $12 | -17.70% | May 2, 2025 |
Financial Forecast
Revenue This Year
176.03M
from 55.25M
Increased by 218.59%
Revenue Next Year
324.57M
from 176.03M
Increased by 84.38%
EPS This Year
-3.26
from -5.29
EPS Next Year
-0.96
from -3.26
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 183.3M | 350.7M | ||||
| Avg | 176.0M | 324.6M | ||||
| Low | 162.7M | 284.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 231.7% | 99.2% | ||||
| Avg | 218.6% | 84.4% | ||||
| Low | 194.4% | 61.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.13 | -0.76 | ||||
| Avg | -3.26 | -0.96 | ||||
| Low | -3.33 | -1.15 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.